Morgan Stanley’s Acurx Pharmaceuticals ACXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$54.2K Hold
2025
Q1
$41.4K Hold
2024
Q4
$86.4K Buy
2024
Q3
$87.8K Sell
2024
Q2
$104K Buy
2024
Q1
$64.7K Sell
2023
Q4
$124K Buy
2023
Q3
$22.5K Buy
2022
Q1
Hold
2021
Q4
Hold